HSCI Community News
Upcoming Events
ISSCR 12th Annual Meeting
Vancouver Convention Center
June 18 - 21

CCRM: The Business of Regenerative Medicine
Toronto, Ontario
July 14 -16
Funding and Awards
Recognitions
All three HSCI faculty to present at Brigham & Women's 'shark tank' are named winners. Congrats to Ben Humphreys, MD, PhD; Jeff Karp, PhD; and Tracy Young-Pearse, PhD.

Richard Lee, MD, is finalist in   Star Family Challenge for Promising Scientific Research
New Members
HSCI welcomes Principal Faculty member, Ya-Chieh Hsu, PhD, who recently joined HSCRB; and Affiliated Faculty members Martin Yarmush, MD, PhD, of HST and MGH's Basak Uygun, PhD.
Job Postings
Media Mentions
5/28/14
Smithsonian.com
The next wave of cancer cures could come from nasty viruses

6/5/14
HealthDay
Study supports durability of Parkinson's treatment
Contact Us
Have anything you'd like to share? Contact [email protected].
A new model of liver regeneration
Fernando Camargo, PhD, and team find Hippo inactivation causes mature liver cells to revert back to stem cell-like state.
Fernando Camargo finds mature liver cells dedifferentiate.



Harvard scientists at Boston Children's Hospital have new evidence in mice that it may be possible to repair a chronically diseased liver by forcing mature liver cells to revert back to a stem cell-like state. The results were published in Cell. Read the full story.
A vaccine for heart attack?
Kiran Musunuru, MD, PhD, and Penn collaborators use gene therapy shot to control cholesterol in mice.
Kiran Musunuru, MD, PhD



Harvard and Brigham & Women's scientists have developed a "genome editing" approach for permanently reducing cholesterol levels in mice with a single injection, potentially reducing heart attack risk by up to 90 percent. Their work was published in Circulation Research. Read on.
Literature Highlights